Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ecallantide for blood loss in heart surgery
NCT00448864Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- May 2007
- Primary completion
- Jul 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of ecallantide, sponsored by Merck & Co.. Started May 2007; status: terminated.
02
Drugs
ecallantide
Beyond the preview
Go deeper on NCT00448864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00448864.